Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-23T15:20:13.392Z Has data issue: false hasContentIssue false

Active site specificity of plasmepsin II

Published online by Cambridge University Press:  01 October 1999

JENNIFER WESTLING
Affiliation:
Department of Biochemistry & Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610-0245
PATTY CIPULLO
Affiliation:
Department of Biochemistry & Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610-0245
SU-HWI HUNG
Affiliation:
Department of Biochemistry & Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610-0245
HOWARD SAFT
Affiliation:
Department of Biochemistry & Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610-0245
JOHN B. DAME
Affiliation:
Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville, Florida 32610-0245
BEN M. DUNN
Affiliation:
Department of Biochemistry & Molecular Biology, College of Medicine, University of Florida, Gainesville, Florida 32610-0245
Get access

Abstract

Members of the aspartic proteinase family of enzymes have very similar three-dimensional structures and catalytic mechanisms. Each, however, has unique substrate specificity. These distinctions arise from variations in amino acid residues that line the active site subsites and interact with the side chains of the amino acids of the peptides that bind to the active site. To understand the unique binding preferences of plasmepsin II, an enzyme of the aspartic proteinase class from the malaria parasite, Plasmodium falciparum, chromogenic octapeptides having systematic substitutions at various positions in the sequence were analyzed. This enabled the design of new, improved substrates for this enzyme (Lys-Pro-Ile-Leu-Phe*Nph-Ala/Glu-Leu-Lys, where * indicates the cleavage point). Additionally, the crystal structure of plasmepsin II was analyzed to explain the binding characteristics. Specific amino acids (Met13, Ser77, and Ile287) that were suspected of contributing to active site binding and specificity were chosen for site-directed mutagenesis experiments. The Met13Glu and Ile287Glu single mutants and the Met13Glu/Ile287Glu double mutant gain the ability to cleave substrates containing Lys residues.

Type
Research Article
Copyright
© 1999 The Protein Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)